Ignite Creation Date:
2025-12-25 @ 2:45 AM
Ignite Modification Date:
2025-12-26 @ 1:25 AM
Study NCT ID:
NCT02050633
Status:
UNKNOWN
Last Update Posted:
2017-11-20
First Post:
2014-01-29
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
PariS -TBI Study: Paris Severe Traumatic Brain Injury Study - 8 Years
Sponsor:
Assistance Publique - Hôpitaux de Paris
Organization:
Study Overview
Official Title:
Eight-year Outcome and Health Care After Severe Traumatic Brain Injury in the Parisian Area
Status:
UNKNOWN
Status Verified Date:
2017-11
Last Known Status:
ENROLLING_BY_INVITATION
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
TCS8
Brief Summary:
The objective of the protocol is to pursue the long-term follow-up of a large cohort of severe traumatic brain injury patients. This outcome is to be described in terms of activity, participation, quality of life, socio-professional outcome, economical consequences and impact on caregivers, and in relation to health care provision.
Secondary objectives are to measure the impact on outcome of several predictive factors; to evaluate evolution of patients since the last (four-year) evaluation.
Secondary objectives are to measure the impact on outcome of several predictive factors; to evaluate evolution of patients since the last (four-year) evaluation.
Detailed Description:
This work represents a part of a larger collaborative prospective study called PariS-TBI (Severe Traumatic Brain Injury in the Parisian area) financed by the French National Authority for Health. The Paris-TBI study was undertaken in 2004, to provide epidemiological data. Patients aged 15 or more were included if they had sustained a severe TBI in the Parisian area during a 20-months period (2005-2007), defined by an initial Coma Glasgow Score (GCS) of 8 or less. Data from patients' demographics, injury characteristics, acute and post acute phase were collected prospectively. A total of 504 patients were included, of which 257 were alive at the time of this study. Patients (n = 134) were evaluated through a phone interview at one year post traumatism, and had a face-to-face evaluation at four years post-injury (n = 147).
Investigations of the present work will be undertaken at eight years after the injury. Patients of the initial cohort will be contacted through post and phone call. Information about this follow up study will be given orally and through written form. Informed consent of patient or legal advisor will be obtained before setting an appointment for the evaluation.
Evaluation will take place either in the patient's place of living, or in a clinical setting in the hospitals Broussais, Paris, France or Raymond Poincaré, Garches, France, according to the patient's choice.
A trained neuropsychologist will lead the evaluations, during an interview with the patient and the informal caregiver, defined as the person (family member or friend), most responsible for day-to-day decision making and care for the patient. If a patient cannot attend the interview, a short questionnaire will be proposed to him by the neuropsychologist by phone.
Demographic and pre-traumatism clinical data will be available from the initial study, as well as data on type and severity of traumatism, and on evolution during acute care. Data from the one-year and the four-year assessments will be available.
Data assessed through the present study will include an evaluation of deficiencies: presence of somatic deficiencies, mood difficulties (Hospital Anxiety and Depression Score), cognitive deficiencies (Dysexecutive Questionnaire, questionnaire of complaints, filled in both by the patient himself and by his proxy). Neuropsychological testing will include the California Verbal Learning Test, Trail Making Test, the WAIS-IV Processing Speed Index, and the 6-Elements Test.
Activities will be evaluated by the Glasgow Outcome Scale-Extended, and specifically through questions addressing driving ability, and ability to perform instrumental activities.
Professional activity and change, and quality of life at work will be assessed through a standardized questionnaire.
Data on patients' clinical care and services will be collected, including medical care, therapies, home assistance, socio-vocational assistance. Unmet need of services and barriers to care access will be assessed through a standardized questionnaire.
Data on the quality of life of the informal caregiver and an evaluation of the burden of care will be collected, using the ZARIT questionnaire. Data on economical consequences of the injury on the patient, and on his care provider will be collected.
The exploitation of this large database will enable an up-to-date description of the long term outcomes of severe TBI patients in the Parisian area. It will be used to clarify the role of several factors on long term activities and participations and on informal care burden.
The comparison with the previous evaluations will allow evaluation of late evolution and of its determinants.
Investigations of the present work will be undertaken at eight years after the injury. Patients of the initial cohort will be contacted through post and phone call. Information about this follow up study will be given orally and through written form. Informed consent of patient or legal advisor will be obtained before setting an appointment for the evaluation.
Evaluation will take place either in the patient's place of living, or in a clinical setting in the hospitals Broussais, Paris, France or Raymond Poincaré, Garches, France, according to the patient's choice.
A trained neuropsychologist will lead the evaluations, during an interview with the patient and the informal caregiver, defined as the person (family member or friend), most responsible for day-to-day decision making and care for the patient. If a patient cannot attend the interview, a short questionnaire will be proposed to him by the neuropsychologist by phone.
Demographic and pre-traumatism clinical data will be available from the initial study, as well as data on type and severity of traumatism, and on evolution during acute care. Data from the one-year and the four-year assessments will be available.
Data assessed through the present study will include an evaluation of deficiencies: presence of somatic deficiencies, mood difficulties (Hospital Anxiety and Depression Score), cognitive deficiencies (Dysexecutive Questionnaire, questionnaire of complaints, filled in both by the patient himself and by his proxy). Neuropsychological testing will include the California Verbal Learning Test, Trail Making Test, the WAIS-IV Processing Speed Index, and the 6-Elements Test.
Activities will be evaluated by the Glasgow Outcome Scale-Extended, and specifically through questions addressing driving ability, and ability to perform instrumental activities.
Professional activity and change, and quality of life at work will be assessed through a standardized questionnaire.
Data on patients' clinical care and services will be collected, including medical care, therapies, home assistance, socio-vocational assistance. Unmet need of services and barriers to care access will be assessed through a standardized questionnaire.
Data on the quality of life of the informal caregiver and an evaluation of the burden of care will be collected, using the ZARIT questionnaire. Data on economical consequences of the injury on the patient, and on his care provider will be collected.
The exploitation of this large database will enable an up-to-date description of the long term outcomes of severe TBI patients in the Parisian area. It will be used to clarify the role of several factors on long term activities and participations and on informal care burden.
The comparison with the previous evaluations will allow evaluation of late evolution and of its determinants.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: